Annual EBIT
-$12.33 M
+$5.59 M+31.20%
March 31, 2023
Summary
- As of March 8, 2025, MDNA annual earnings before interest & taxes is -$12.33 million, with the most recent change of +$5.59 million (+31.20%) on March 31, 2023.
- During the last 3 years, MDNA annual EBIT has fallen by -$6.13 million (-98.88%).
Performance
MDNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$3.31 M
-$1.12 M-50.95%
June 30, 2023
Summary
- As of March 8, 2025, MDNA quarterly earnings before interest & taxes is -$3.31 million, with the most recent change of -$1.12 million (-50.95%) on June 30, 2023.
- Over the past year, MDNA quarterly EBIT has increased by +$73.70 thousand (+2.18%).
Performance
MDNA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$12.26 M
+$73.70 K+0.60%
June 30, 2023
Summary
- As of March 8, 2025, MDNA TTM earnings before interest & taxes is -$12.26 million, with the most recent change of +$73.70 thousand (+0.60%) on June 30, 2023.
- Over the past year, MDNA TTM EBIT has increased by +$4.02 million (+24.69%).
Performance
MDNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MDNA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.2% | +2.2% | +24.7% |
| 3 y3 years | -98.9% | -80.5% | -73.3% |
| 5 y5 years | -112.7% | -307.6% | -144.2% |
MDNA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.4% | +51.0% | +17.2% | at high | +63.1% |
| 5 y | 5-year | +242.3% | +45.4% | +82.3% | +97.2% | +144.1% | +64.4% |
| alltime | all time | +1111.2% | +45.4% | >+9999.0% | +97.2% | >+9999.0% | +64.4% |
Medicenna Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$3.31 M(+51.0%) | -$12.26 M(-0.6%) |
| Mar 2023 | -$12.33 M(-31.2%) | -$2.20 M(-39.4%) | -$12.33 M(-2.2%) |
| Dec 2022 | - | -$3.62 M(+15.9%) | -$12.60 M(-2.0%) |
| Sep 2022 | - | -$3.13 M(-7.8%) | -$12.87 M(-21.0%) |
| Jun 2022 | - | -$3.39 M(+37.3%) | -$16.28 M(-9.3%) |
| Mar 2022 | -$17.92 M(+36.1%) | -$2.47 M(-36.5%) | -$17.95 M(-10.2%) |
| Dec 2021 | - | -$3.89 M(-40.6%) | -$19.99 M(-0.8%) |
| Sep 2021 | - | -$6.54 M(+29.1%) | -$20.15 M(+22.0%) |
| Jun 2021 | - | -$5.06 M(+12.3%) | -$16.51 M(+24.3%) |
| Mar 2021 | -$13.17 M(+112.4%) | -$4.51 M(+11.3%) | -$13.29 M(+23.4%) |
| Dec 2020 | - | -$4.05 M(+39.4%) | -$10.77 M(+26.1%) |
| Sep 2020 | - | -$2.90 M(+58.0%) | -$8.54 M(+20.8%) |
| Jun 2020 | - | -$1.84 M(-7.6%) | -$7.07 M(+14.1%) |
| Mar 2020 | -$6.20 M | -$1.99 M(+9.3%) | -$6.20 M(+23.5%) |
| Dec 2019 | - | -$1.82 M(+27.2%) | -$5.02 M(+11.6%) |
| Sep 2019 | - | -$1.43 M(+48.3%) | -$4.50 M(+20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$963.90 K(+19.2%) | -$3.75 M(+4.2%) |
| Mar 2019 | -$3.60 M(-37.9%) | -$808.60 K(-37.6%) | -$3.60 M(-5.9%) |
| Dec 2018 | - | -$1.30 M(+90.5%) | -$3.82 M(-9.8%) |
| Sep 2018 | - | -$680.10 K(-16.4%) | -$4.24 M(-13.8%) |
| Jun 2018 | - | -$813.30 K(-21.3%) | -$4.91 M(-14.8%) |
| Mar 2018 | -$5.80 M(-1.1%) | -$1.03 M(-39.6%) | -$5.77 M(-28.6%) |
| Dec 2017 | - | -$1.71 M(+26.0%) | -$8.08 M(+1.0%) |
| Sep 2017 | - | -$1.36 M(-18.6%) | -$8.00 M(+20.4%) |
| Jun 2017 | - | -$1.67 M(-50.1%) | -$6.64 M(+33.3%) |
| Mar 2017 | -$5.86 M(+475.9%) | -$3.34 M(+104.6%) | -$4.99 M(+201.8%) |
| Dec 2016 | - | -$1.63 M(>+9900.0%) | -$1.65 M(+8416.0%) |
| Sep 2016 | - | -$4700.00(-43.4%) | -$19.40 K(-85.2%) |
| Jun 2016 | - | -$8300.00(+29.7%) | -$131.40 K(-2.7%) |
| Mar 2016 | -$1.02 M | -$6400.00(-94.5%) | -$135.10 K(+5.0%) |
| Sep 2015 | - | -$116.70 K(+872.5%) | -$128.70 K(+972.5%) |
| Jun 2015 | - | -$12.00 K | -$12.00 K |
FAQ
- What is Medicenna Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Medicenna Therapeutics?
- What is Medicenna Therapeutics annual EBIT year-on-year change?
- What is Medicenna Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Medicenna Therapeutics?
- What is Medicenna Therapeutics quarterly EBIT year-on-year change?
- What is Medicenna Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Medicenna Therapeutics?
- What is Medicenna Therapeutics TTM EBIT year-on-year change?
What is Medicenna Therapeutics annual earnings before interest & taxes?
The current annual EBIT of MDNA is -$12.33 M
What is the all time high annual EBIT for Medicenna Therapeutics?
Medicenna Therapeutics all-time high annual earnings before interest & taxes is -$1.02 M
What is Medicenna Therapeutics annual EBIT year-on-year change?
Over the past year, MDNA annual earnings before interest & taxes has changed by +$5.59 M (+31.20%)
What is Medicenna Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of MDNA is -$3.31 M
What is the all time high quarterly EBIT for Medicenna Therapeutics?
Medicenna Therapeutics all-time high quarterly earnings before interest & taxes is -$4700.00
What is Medicenna Therapeutics quarterly EBIT year-on-year change?
Over the past year, MDNA quarterly earnings before interest & taxes has changed by +$73.70 K (+2.18%)
What is Medicenna Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of MDNA is -$12.26 M
What is the all time high TTM EBIT for Medicenna Therapeutics?
Medicenna Therapeutics all-time high TTM earnings before interest & taxes is -$12.00 K
What is Medicenna Therapeutics TTM EBIT year-on-year change?
Over the past year, MDNA TTM earnings before interest & taxes has changed by +$4.02 M (+24.69%)